148 related articles for article (PubMed ID: 11457994)
1. Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism.
Thullier P; Demangel C; Bedouelle H; Mégret F; Jouan A; Deubel V; Mazié JC; Lafaye P
J Gen Virol; 2001 Aug; 82(Pt 8):1885-1892. PubMed ID: 11457994
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive mapping of functional epitopes on dengue virus glycoprotein E DIII for binding to broadly neutralizing antibodies 4E11 and 4E5A by phage display.
Frei JC; Kielian M; Lai JR
Virology; 2015 Nov; 485():371-82. PubMed ID: 26339794
[TBL] [Abstract][Full Text] [Related]
3. Engineered Dengue Virus Domain III Proteins Elicit Cross-Neutralizing Antibody Responses in Mice.
Frei JC; Wirchnianski AS; Govero J; Vergnolle O; Dowd KA; Pierson TC; Kielian M; Girvin ME; Diamond MS; Lai JR
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976679
[TBL] [Abstract][Full Text] [Related]
4. A recombinant Fab neutralizes dengue virus in vitro.
Thullier P; Lafaye P; Mégret F; Deubel V; Jouan A; Mazié JC
J Biotechnol; 1999 Apr; 69(2-3):183-90. PubMed ID: 10361725
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for dengue virus broad cross-neutralization by humanized monoclonal antibody 513.
Wong YH; Kumar A; Liew CW; Tharakaraman K; Srinivasaraghavan K; Sasisekharan R; Verma C; Lescar J
Sci Rep; 2018 May; 8(1):8449. PubMed ID: 29855525
[TBL] [Abstract][Full Text] [Related]
6. Characterization of two anti-dengue human monoclonal antibodies prepared from PBMCs of patients with dengue illness in Thailand.
Li ZY; Yamashita A; Kawashita N; Sasaki T; Pan Y; Ono KI; Ikuta K; Li YG
Acta Virol; 2016 Jun; 60(2):166-73. PubMed ID: 27265466
[TBL] [Abstract][Full Text] [Related]
7. Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins.
Falconar AK
Arch Virol; 1999; 144(12):2313-30. PubMed ID: 10664386
[TBL] [Abstract][Full Text] [Related]
8. Generation of Monoclonal Antibodies against Dengue Virus Type 4 and Identification of Enhancing Epitopes on Envelope Protein.
Tang CT; Liao MY; Chiu CY; Shen WF; Chiu CY; Cheng PC; Chang GJ; Wu HC
PLoS One; 2015; 10(8):e0136328. PubMed ID: 26309127
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica.
Roehrig JT; Bolin RA; Kelly RG
Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950
[TBL] [Abstract][Full Text] [Related]
10. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
Li J; Watterson D; Chang CW; Che XY; Li XQ; Ericsson DJ; Qiu LW; Cai JP; Chen J; Fry SR; Cheung STM; Cooper MA; Young PR; Kobe B
Structure; 2018 Jan; 26(1):51-59.e4. PubMed ID: 29249606
[TBL] [Abstract][Full Text] [Related]
11. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
Sukupolvi-Petty S; Austin SK; Purtha WE; Oliphant T; Nybakken GE; Schlesinger JJ; Roehrig JT; Gromowski GD; Barrett AD; Fremont DH; Diamond MS
J Virol; 2007 Dec; 81(23):12816-26. PubMed ID: 17881453
[TBL] [Abstract][Full Text] [Related]
12. An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2.
Tang CT; Li PC; Liu IJ; Liao MY; Chiu CY; Chao DY; Wu HC
PLoS Negl Trop Dis; 2015; 9(7):e0003903. PubMed ID: 26135599
[TBL] [Abstract][Full Text] [Related]
13. Human monoclonal single-chain antibodies specific to dengue virus envelope protein.
Saokaew N; Poungpair O; Panya A; Tarasuk M; Sawasdee N; Limjindaporn T; Chaicumpa W; Yenchitsomanus P
Lett Appl Microbiol; 2014 Mar; 58(3):270-7. PubMed ID: 24266517
[TBL] [Abstract][Full Text] [Related]
14. On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes.
Rajamanonmani R; Nkenfou C; Clancy P; Yau YH; Shochat SG; Sukupolvi-Petty S; Schul W; Diamond MS; Vasudevan SG; Lescar J
J Gen Virol; 2009 Apr; 90(Pt 4):799-809. PubMed ID: 19264660
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of a monoclonal antibody that cross-reacts with the envelope protein from the four dengue virus serotypes.
León-Juárez M; García-Cordero J; Santos-Argumedo L; Romero-Ramírez H; García-Machorro J; Bustos-Arriaga J; Gutiérrez-Castañeda B; Sepúlveda NV; Mellado-Sánchez G; Cedillo-Barrón L
APMIS; 2013 Sep; 121(9):848-58. PubMed ID: 23331315
[TBL] [Abstract][Full Text] [Related]
16. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K
J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930
[TBL] [Abstract][Full Text] [Related]
17. Use of synthetic peptides to represent surface-exposed epitopes defined by neutralizing dengue complex- and flavivirus group-reactive monoclonal antibodies on the native dengue type-2 virus envelope glycoprotein.
Falconar AKI
J Gen Virol; 2008 Jul; 89(Pt 7):1616-1621. PubMed ID: 18559931
[TBL] [Abstract][Full Text] [Related]
18. Direct and indirect interactions in the recognition between a cross-neutralizing antibody and the four serotypes of dengue virus.
Lisova O; Belkadi L; Bedouelle H
J Mol Recognit; 2014 Apr; 27(4):205-14. PubMed ID: 24591178
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
Gromowski GD; Barrett AD
Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
[TBL] [Abstract][Full Text] [Related]
20. Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies.
Beasley DW; Aaskov JG
Virology; 2001 Jan; 279(2):447-58. PubMed ID: 11162801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
